Research Article
Aberrant Expression of EZH2 in Pediatric Patients with Myelodysplastic Syndrome: A Potential Biomarker of Leukemic Evolution
Table 2
Scale of measure for EZH2 expression in pediatric MDS.
| ||||||||||||||||||||||||||||
Notation in the form of [0,1) to indicate the numbers between 0 and 1; [1,3) to indicate the numbers between 1 and 3; [3,13) to indicate the numbers between 3 and 13. |